Patents by Inventor Richard Ambinder

Richard Ambinder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMAGING AND THERAPY OF VIRUS-ASSOCIATED TUMORS
    Publication number: 20160354498
    Abstract: The present invention features compositions and methods for detecting, selecting a treatment method for, monitoring, and treating a neoplasia associated with a viral infection.
    Type: Application
    Filed: March 17, 2016
    Publication date: December 8, 2016
    Inventors: Martin G. Pomper, Richard Ambinder, Jun O. Liu, Curtis R. Chong, Jianmeng Chen
  • IMAGING AND THERAPY OF VIRUS-ASSOCIATED TUMORS
    Publication number: 20110176998
    Abstract: The present invention features compositions and methods for detecting, selecting a treatment method for, monitoring, and treating a neoplasia associated with a viral infection.
    Type: Application
    Filed: October 13, 2010
    Publication date: July 21, 2011
    Applicant: THE JOHNS HOPKINS UNIVERSITY
    Inventors: Martin G. Pomper, Richard Ambinder, Jun O. Liu, Curtis R. Chong, Jianmeng Chen
  • Cancer immunotherapy with a viral antigen-defined, immunomodulator-secreting cell vaccine
    Publication number: 20060233770
    Abstract: A human cell line, which lacks major histocompatibility class I (MHC-I) antigens and major histocompatibility class II (MHC-II) antigens and which has been modified to comprise and express (i) a nucleotide sequence encoding an immunomodulator and (ii) a nucleotide sequence encoding a viral antigen, and a method of inducing or stimulating an immune response in a human to a viral-associated disease or cancer comprising administering to the human (i) the aforementioned human cell line in an amount sufficient to induce or stimulate an immune response to the viral associated disease or cancer, (ii) a human cell line, which lacks MHC-I and MHC-11 antigens and which has been modified to comprise and express a nucleotide sequence encoding an immunomodulator, and a human cell line, which lacks MHC-I and MHC-II antigens and which has been modified to comprise and express a nucleotide sequence encoding an antigen of EBV, simultaneously or sequentially in either order, by the same or different routes, in amounts sufficie
    Type: Application
    Filed: September 19, 2003
    Publication date: October 19, 2006
    Applicant: Johns Hopkins University School of Medicine
    Inventors: Richard Ambinder, Yiping Yang, Ivan Borrello, Hyam Levitsky